Reviva Pharmaceuticals Holdings (RVPH) Live Share Price, Invest From India

Reviva Pharmaceuticals Holdings Stock Performance

as on September 1, 2026 at 6:52 am IST

Day's Low
Day's High
$0.47
Day's Price Range
$0.52
$0.48
2.08%
Downside
8.33%
Upside
52 Week's Low
52 Week's High
$0.26
52-Week Price Range
$17.20
$0.48
45.42%
Downside
3483.33%
Upside

Reviva Pharmaceuticals Holdings share price movements today

Previous Close: $0.52
Open: $0.47
Volume: 137.5K
Market Cap: $6.8M
Day's Low - High: $0.47 - $0.52
52 Week Low - High: $0.26 - $17.20

Reviva Pharmaceuticals Holdings Historical Returns

1 Month Return: + 18.41 %
3 Month Return: + 26.71 %
1 Year Return: -94.24 %
3 Year Return: -99.34 %
5 Year Return: -99.41 %

Reviva Pharmaceuticals Holdings Stock Fundamentals & Key Indicators

Check Reviva Pharmaceuticals Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.8M

EPS (TTM)

-0.85

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-10.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-176.60%

Reviva Pharmaceuticals Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Reviva Pharmaceuticals Holdings with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Reviva Pharmaceuticals Holdings	BUY	$6.8M	-99.41%	NA	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Alnylam Pharma	BUY	$31.7B	17.71%	41.16	16.13%	NA
Vertex Pharmaceuticals	BUY	$137.2B	170.45%	31.92	86.04%	NA
Regeneron	BUY	$85.8B	17.94%	19.9	84.86%	0.44%

Stock Returns calculator for Reviva Pharmaceuticals Holdings Stock including INR - Dollar returns

The Reviva Pharmaceuticals Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Reviva Pharmaceuticals Holdings investment value today

Current value as on today

₹5,767

Returns

-₹94,233

(-94.23%)

Returns from Reviva Pharmaceuticals Holdings Stock

-₹94,667 (-94.67%)

Dollar Impact

₹433 (+0.43%)

Analyst Recommendation on Reviva Pharmaceuticals Holdings Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Reviva Pharmaceuticals Holdings. Average target price of $17.5

Reviva Pharmaceuticals Holdings Share Price Target

Get share price movements and forecasts by analysts on Reviva Pharmaceuticals Holdings.

What analysts predicted

97.26%UPSIDE

Target Price

$17.5

Current Price

$0.48

Analyzed by

11 Analysts

Target

$17.50

Reviva Pharmaceuticals Holdings target price $17.5, a slight upside of 97.26% compared to current price of $0.48. According to 11 analysts rating.

Reviva Pharmaceuticals Holdings Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-
Operating Income	-7	-8	-8	-6	-6	-6	-4	-3	-3
EBITDA	-6	-7	-8	-	-6	-6	-4	-3	-3
Interest Expense	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-7	-7	-8	-6	-6	-6	-4	-3	-3
Income Tax Expense	0	0	-	-	0	0	0	0	0
Net Income	-7	-7	-8	-6	-6	-6	-4	-3	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Reviva Pharmaceuticals Holdings Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	0	-	-	-	-	-
Operating Income	0	-2	-10	-24	-39	-30	-20
EBITDA	0	-2	-8	-24	-39	-29	-19
Interest Expense	0	1	0	0	0	0	0
Depreciation	0	0	0	-	-	-	-
Income Before Tax	0	-3	-8	-24	-39	-29	-19
Income Tax Expense	0	0	0	0	0	0	0
Net Income	0	-3	-8	-24	-39	-29	-19
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Reviva Pharmaceuticals Holdings Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-7	-8	-6	-6	-6	-4	-3	-3	-5,643,814
Operating Cash Flow	-8	-4	-9	-8	-5	-5	-5	-3	-5,916,694
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	2	3	17	0	10	8	7	11	11,367,854
Change in Cash	-5	0	7	-8	5	2	1	7	19,889,937

Reviva Pharmaceuticals Holdings Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	0	-3	-8	-24	-39	-29	-19
Operating Cash Flow	0	-4	-10	-18	-28	-33	-24
Investing Cash Flow	-	-	-	-	-	-	-
Financing Cash Flow	0	12	31	7	33	23	25
Change in Cash	0	8	20	-11	4	-9	0

Mutual Funds that own Reviva Pharmaceuticals Holdings Stock

Check out the Mutual Funds with significant holdings in Reviva Pharmaceuticals Holdings.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	0.896747%	117567
Victory Portfolios III	0.013454%	1764
John Hancock Variable Insurance Trust	0.0008%	105

Global Institutional Holdings in Reviva Pharmaceuticals Holdings

Funds	Holdings
Scott Kapnick	5.81%

Reviva Pharmaceuticals Holdings News & Key Events

Insights on Reviva Pharmaceuticals Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, REVOLUTION Medicines Inc has given 473.9% return, outperforming this stock by 573.7%
NO EFFECT
Against Peers
In the last 1 year, REVOLUTION Medicines Inc has given 268.4% return, outperforming this stock by 366.4%
NEGATIVE IMPACT
Price Dip
In the last 7 days, RVPH stock has moved down by -58.2%

About Reviva Pharmaceuticals Holdings

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis. It also engages in the clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis. In addition, the company is in preclinical development for the treatment of psoriasis; and RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.

Organisation	Reviva Pharmaceuticals Holdings
Headquarters	10080 N. Wolfe Road, Cupertino, CA, United States, 95014
Industry	Biotechnology
CEO	Dr. Laxminarayan Bhat Ph.D.
E-voting on shares	Click here to vote

Key Management of Reviva Pharmaceuticals Holdings

Name	Title
Dr. Laxminarayan Bhat Ph.D.	Founder, CEO, President & Director
Mr. Narayan Prabhu	CFO, Treasurer & Secretary

FAQs

What is Reviva Pharmaceuticals Holdings share price today?

Reviva Pharmaceuticals Holdings share price today is $0.48 as on September 1, 2026 at 1:22 am IST at the close of the market. Reviva Pharmaceuticals Holdings share today touched a day high of $0.52 and a low of $0.47.

What is the 52 week high and 52 week low for Reviva Pharmaceuticals Holdings share?

Reviva Pharmaceuticals Holdings share touched a 52 week high of $17.20 on October 7, 2025 and a 52 week low of $0.26 on May 13, 2026. Reviva Pharmaceuticals Holdings stock price today i.e. September 1, 2026 at 1:22 am IST is closed at $0.48,which is 97.21% down from its 52 week high and 83.21% up from its 52 week low.

What is Reviva Pharmaceuticals Holdings's market capitalisation today?

Reviva Pharmaceuticals Holdings market capitalisation is $0.00T as on September 1, 2026 at 1:22 am IST.

How to invest in Reviva Pharmaceuticals Holdings Stock (RVPH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Reviva Pharmaceuticals Holdings on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Reviva Pharmaceuticals Holdings Shares that will get you 3.1250 shares as per Reviva Pharmaceuticals Holdings share price of $0.48 per share as on September 1, 2026 at 1:22 am IST.

What is the minimum amount required to buy Reviva Pharmaceuticals Holdings Stock (RVPH) from India?

Indian investors can start investing in Reviva Pharmaceuticals Holdings (RVPH) shares with as little as ₹95.152 or $1 (as of September 1, 2026 at 4:26 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹951.52 in Reviva Pharmaceuticals Holdings stock (as per the Rupee-Dollar exchange rate as on September 1, 2026 at 4:26 am IST). Based on Reviva Pharmaceuticals Holdings share’s latest price of $0.48 as on September 1, 2026 at 1:22 am IST, you will get 20.8333 shares of Reviva Pharmaceuticals Holdings. Learn more about fractional shares .

What are the returns that Reviva Pharmaceuticals Holdings has given to Indian investors in the last 5 years?

Reviva Pharmaceuticals Holdings stock has given -99.41% share price returns and 30.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?